More baby formula hitting store shelves soon, FDA says


Millions of boxes of infant formula will hit US store shelves in the coming weeks and help facilitate a national infant formula shortageaccording to the Food and Drug Administration.

Abbott Nutrition of Illinois plans to ship 300,000 boxes of specialty formulas, the FDA announced Tuesday. But those supplies won’t be released until after the company’s factory in Sturgis, Michigan reopens on June 4.

In addition to Abbott’s shipment, UK-based Kendal Nutricare said it will ship 2 million boxes of formula to the United States, with the products expected to be in stores next month, it said. the FDA. Kendal’s shipment could be the first of many overseas infant formula shipments, FDA Commissioner Dr. Robert Califf said in a statement.

“We anticipate that other infant formulas can be imported quickly and safely into the United States in the near term based on ongoing discussions with manufacturers and suppliers around the world,” he said.

FDA eases restrictions as families face formula shortage


Formula supplies have become tight this spring, prompting major retailers like Target and Walgreens to limit the amount buyers can buy.

Supply chain issues are partly to blame, as manufacturers struggle to get key ingredients and hire enough workers for their production plants.

The infant formula shortage came to a head when Abbott’s plant in Sturgis, Michigan, became the largest infant formula plant in the United States. launched a massive recall in February after parents reported that their children had fallen ill after consuming the company’s products. The FDA later reported that Abbott had unsanitary conditions at his factory.

Abbott plans to launch EleCare infant formula, but only for “people in need of an urgent and life-saving supply of this specialty formula,” the FDA said. In a statement, Abbott said it aims to ship the product around June 20.

Abbott, FDA reach agreement on plan to reopen infant formula factory to address shortage


The shipment of EleCare slated for release next month was not among the batch of preparations recalled in February, FDA officials said. Still, the next shipment “will undergo enhanced microbiological testing before release,” the agency said. Abbott also produces other popular formula brands, including Similac and Alimentum.

Kendal’s inbound shipment of Kendamil-branded formula will come from a plant that can technically produce 10 million boxes of formula per year, but is currently operating at half capacity, the company said. Kendal has set up a website so US customers can find out exactly when the formula shipment will arrive at nearby stores.

“We have received the call for assistance from the FDA and Kendamil is ready to act,” Kendal Nutricare CEO Ross McMahon said in a statement.


Comments are closed.